Items where Author is "Ali, SA"
![]() | Up a level |
ALI, K.S., REES, R.C., TERRELL-NIELD, C. and ALI, S.A., 2013. Virulence loss and amastigote transformation failure determines host cell responses to Leishmania mexicana. Parasite Immunology. ISSN 1365-3024
ALI, S.A., REZVAN, H., MCARDLE, S.E., KHODADADI, A., ASTEAL, F.A. and REES, R.C., 2009. CTL responses to Leishmania mexicana gp63-cDNA vaccine in a murine model. Parasite Immunology, 31 (7), pp. 373-383.
ASSUDANI, D.P., MCARDLE, S.E., AHMAD, M., LI, G., REES, R.C. and ALI, S.A., 2008. Vaccination strategies for malignant diseases. In: Treatment of cancer. Hodder Arnold, p. 167.
ASSUDANI, D.P., AHMAD, M., LI, G., REES, R.C. and ALI, S.A., 2006. Immunotherapeutic potential of DISC-HSV and OX40L in cancer. Cancer Immunology Immunotherapy, 55 (1), pp. 104-111. ISSN 0340-7004
ASSUDANI, D.P., AHMAD, M., LI, G., REES, R.C. and ALI, S.A., 2006. Immunotherapeutical potential of DISC-HSV and OX40L in cancer. Cancer Immunology, Immunotherapy, 55 (1), pp. 104-111. ISSN 0340-7004
LI, G., ALI, S.A., MCARDLE, S.E., MIAN, S., AHMAD, M., MILES, A. and REES, R.C., 2005. Immunity to tumour antigens. Current Pharmaceutical Design, 11 (27), pp. 3501-3509. ISSN 1381-6128
ROJAS, J.M., MCARDLE, S.E.B., HORTON, R.B.V., BELL, M., MIAN, S., LI, G., ALI, S.A. and REES, R.C., 2005. Peptide immunisation of HLA-DR-transgenic mice permits the identification of a novel HLA-DRbeta 1*0101-and HLA-DRbeta 1*0401-restricted epitope from p53. Cancer Immunology Immunotherapy, 54 (3), pp. 243-253. ISSN 0340-7004
AHMAD, M., REES, R.C., MCARDLE, S.E., LI, G., MIAN, S., ENTWISLE, C., LOUDON, P. and ALI, S.A., 2005. Regulation of CTL responses to MHC-restricted class I peptide of the gp70 tumour antigen by splenic parenchymal CD4(+) T cells in mice failing immunotherapy with DISC-mGM-CSF. International Journal of Cancer, 115 (6), pp. 951-959. ISSN 0020-7136
ALI, S.A., AHMAD, M., LYNAM, J., MCLEAN, C.S., ENTWISLE, C., LOUDON, P., CHOOLUN, E., MCARDLE, S.E., LI, G., MIAN, S. and REES, R.C., 2004. Anti-tumour therapeutic efficacy of OX40L in murine tumour model. Vaccine, 22 (2728), pp. 3585-3594. ISSN 0264-410X
AHMAD, M., REES, R.C. and ALI, S.A., 2004. Escape from immunotherapy: possible mechanisms that influence tumor regression/progression. Cancer Immunology, Immunotherapy, 53 (10), pp. 844-854. ISSN 0340-7004
ASSUDANI, D.P., AHMAD, M., LI, G., REES, R.C. and ALI, S.A., 2004. Immunotherapeutical potential of DISC-HSV and OX40L in cancer. In: Conference on Progress in Vaccination Against Cancer, Frendenstadt Lauterbad, Germany, 22-25 September 2004, Frendenstadt Lauterbad, Germany.
MCARDLE, S.E., ALI, S.A., LI, G., MIAN, S. and REES, R.C., 2003. Phenotypic and functional differences of dendritic cells generated under different in vitro conditions. Methods in Molecular Medicine, 81, pp. 359-375.
REES, R.C., MCARDLE, S.E., MIAN, S., LI, G., AHMAD, M., PARKINSON, R. and ALI, S.A., 2002. Disabled infectious single cycle-herpes simplex virus (DISC-HSV) as a vector for immunogene therapy of cancer. Current Opinion in Molecular Therapeutics, 4 (1), pp. 49-53. ISSN 1464-8431
ALI, S.A., LYNAM, J., MCLEAN, C.S., ENTWISLE, C., LOUDON, P., ROJAS, J.M., MCARDLE, S.E., LI, G., MIAN, S. and REES, R.C., 2002. Tumor regression induced by intratumor therapy with a disabled infectious single cycle (DISC) herpes simplex virus (HSV) vector, DISC/HSV/murine granulocyte-macrophage colony-stimulating factor, correlates with antigen-specific adaptive immunity. Journal of Immunology, 168 (7), pp. 3512-3519. ISSN 0022-1767
LOUDON, P.T., CHOOLUN, E., CURRY, J., DAY, D.A., DUNCAN, I.A., ENTWISLE, C., LOWDEN, R.C., MCLEAN, C.S., MARTIN, G., SHAW, M.L., GORE, M., HARRIS, A.L., ALI, S.A., LYNAM, J. and REES, R.C., 2001. Phase I clinical trial of DISC-GMCSF for immunotherapy of metastatic melanoma. Cancer Gene Therapy, 8. ISSN 0929-1903
ALI, S.A., MCLEAN, C.S., BOURSNELL, M.E.G., MARTIN, G., HOLMES, C.L., REEDER, S., ENTWISLE, C., BLAKELEY, D.M., SHIELDS, J.G., TODRYK, S., VILE, R., ROBINS, R.A. and REES, R.C., 2000. Preclinical evaluation of 'whole' cell vaccines for prophylaxis and therapy using a disabled infectious single cycle-herpes simplex virus vector to transduce cytokine genes. Cancer Research, 60 (6), pp. 1663-1670. ISSN 0008-5472
ALI, S.A., REES, R.C., ANDERSON, D.Q., REED, M.W.R., GOEPEL, J.R. and BROWN, N.J., 2000. Trafficking of 'immune' CD4(+)/CD8(+) T-lymphocytes into the RENCA tumour microcirculation in vivo in mice. British Journal of Cancer, 83 (8), pp. 1061-1068. ISSN 0007-0920
PREST, S.J., REES, R.C., MURDOCH, C., MARSHALL, J.F., COOPER, P.A., BIBBY, M., LI, G. and ALI, S.A., 1999. Chemokines induce the cellular migration of MCF-7 human breast carcinoma cells: Subpopulations of tumour cells display positive and negative chemotaxis and differential in vivo growth potentials. Clinical & Experimental Metastasis, 17 (5), pp. 389-396. ISSN 0262-0898
BOURSNELL, M.E.G., ENTWISLE, C., ALI, S.A., SIVASUBRAMANIAM, S.D., REEDER, S., MCLEAN, C.S., BLAKELEY, D.M., MILLER, J., HILL, S., SHIELDS, J.G., INGLIS, S.C. and REES, R.C., 1998. Disabled infectious single cycle (DISC) herpes simplex virus as a vector for immunotherapy of cancer. Gene Therapy of Cancer, 451, pp. 379-384. ISSN 0065-2598
GENG, L., ALI, S.A., MARSHALL, J.F., MACKAY, C.L., HART, I.R., DELCOMMENCE, M., STREULI, C.H. and REES, R.C., 1998. Fibronectin is chemotactic for CT26 colon carcinoma cells: sub-lines selected for increased chemotaxis to fibronectin display decreased tumorigenicity and lung colonization. Clinical & Experimental Metastasis, 16 (8), pp. 683-691. ISSN 0262-0898
YOUNGS, S.A., ALI, S.A., TAUB, D.D. and REES, R.C., 1997. Alpha and beta chemokines are chemotactic to human breast carcinoma cell lines. International Journal of Cancer, 71, pp. 1-10.
YOUNGS, S.J., ALI, S.A., TAUB, D.D. and REES, R.C., 1997. Chemokines induce migrational responses in human breast carcinoma cell lines. International Journal of Cancer, 71 (2), pp. 257-266. ISSN 0020-7136
ANDALIB, A.R., LAWRY, J., ALI, S.A., MURRAY, A.K., SISLEY, K., SILCOCKS, P., HERLYN, M. and REES, R.C., 1997. Cytokine modulation of antigen expression in human melanoma cell lines derived from primary and metastatic tumour tissues. Melanoma Research, 7 (1), pp. 32-42. ISSN 0960-8931
BOURSNELL, M.E.G., ENTWISLE, C., ALI, S.A., SIVASUBRAMANIAM, S.D., REEDER, S., MCLEAN, C.S., BLAKELEY, D.M., SHIELDS, J.G., INGLIS, S.C. and REES, R.C., 1997. Disabled infectious single cycle (DISC) herpes simplex virus as a vector for immunotherapy of cancer. Cancer Gene Therapy, 4 (5), p. 321. ISSN 0929-1903
TAMIZIFAR, H., JENNINGS, R., ALI, S.A. and POTTER, C.W., 1997. Induction of IL-2 and IFN-gamma in BALB/c mice immunised with subunit influenza a vaccine in combination with whole cell or acellular DTP vaccine. Journal of Medical Microbiology, 46 (1), pp. 61-66. ISSN 0022-2615
CROSS, A.K., RICHARDSON, V., ALI, S.A., PALMER, I., TAUB, D.D. and REES, R.C., 1997. Migration responses of human monocytic cell lines to alpha- and beta-chemokines. Cytokine, 9 (7), pp. 521-528. ISSN 1043-4666
ZUBAIR, A.C., ALI, S.A., REES, R.C., GOEPEL, J.R., WINFIELD, D.A. and GOYNS, M.H., 1996. Analysis of the colonization of unirradiated and irradiated SCID mice by human lymphoma and non-malignant lymphoid cells. Leukemia & Lymphoma, 22, pp. 463-471. ISSN 1042-8194
YOUNGS, S.J., ALI, S.A., TAUB, D.D. and REES, R.C., 1996. Chemokines induce migratory responses in human breast carcinoma cell lines. Immunology, 89. ISSN 0019-2805
ALI, S.A., LI, G., YOUNGS, S. and REES, R.C., 1996. Interleukin-15 induced tumour cell migration. Immunology, 89. ISSN 0019-2805
ZUBAIR, A.C., ALI, S.A., REES, R.C., GOEPEL, J.R. and GOYNS, M.H., 1996. Investigation of the effect of BB-94 (batimastat) on the colonization potential of human lymphoma cells in SCID mice. Cancer Letters, 107 (1), pp. 91-95. ISSN 0304-3835
ALI, S.A., HAWRYLOWICZ, C.M., PEEL, J., GRIFFITH, C.D.M. and REES, R.C., 1984. Human spleen cells mediating mediating natural killing: altered natural cytotoxicity of spleen effector cells from patients with carcinoma. Journal of Cancer Research and Clinical Oncology, 106, pp. 202-209.